Vifor Pharma AG (SWX:VIFN) entered into a definitive agreement to acquire Sanifit Therapeutics S.A. from group of investor for €380 million on November 22, 2021. Closing of the transaction is contingent on customary closing conditions, including the FDI procedure in Spain and merger filings in certain countries, and is expected to take place in Q1 2022. Enrique Carretero, Carlos Martín, Roberto Concha, Manuel Alonso, Alan Zocolillo, Randall Sunberg and Teisha C Johnson of Baker & Mckenzie Barcelona Slp acted as legal advisors to Vifor Pharma AG.

Enrique Carretero of Baker & McKenzie Madrid S.L. advised Sanifit Therapeutics S.A. in the deal.